SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS

被引：0
|
作者：
Onwordi, Ellis Chika [1 ]
Halff, Els [2 ]
Whitehurst, Thomas [1 ]
Mansur, Ayla [3 ]
Cotel, Marie-Caroline [2 ]
Wells, Lisa [4 ]
Creeney, Hannah [2 ]
Bonsall, David [4 ]
Rogdaki, Maria [1 ]
Shatalina, Ekaterina [1 ]
Marques, Tiago Reis [1 ]
Rabiner, Eugenii [4 ]
Gunn, Roger [3 ]
Natesan, Sridhar [2 ]
Vernon, Anthony [2 ]
Howes, Oliver D. [1 ]
机构：
[1] Hammersmith Hosp, MRC London Inst Med Sci, London, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[3] Imperial Coll London, London, England
[4] Invicro Imaging Serv, Boston, MA USA
来源：
SCHIZOPHRENIA BULLETIN | 2020年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O11.3
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [21] The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae
    Madeo, Marianna
    Kovacs, Attila D.
    Pearce, David A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33066 - 33071
  • [22] Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling
    Ohno, Yukihiro
    Ishihara, Shizuka
    Terada, Ryo
    Kikuta, Miki
    Sofue, Nobumasa
    Kawai, Yoshiko
    Serikawa, Tadao
    Sasa, Masashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (03) : 415 - 420
  • [23] Association between the synaptic vesicle protein SV2A and mesial temporal lobe epilepsy
    Heils, A.
    Elger, C.
    EPILEPSIA, 2006, 47 : 11 - 12
  • [24] Synaptic vesicle protein 2A (SV2A) mediates anticonvulsant effects of levetiracetam in mice
    Rafał Kaminski
    Pharmacological Reports, 2010, 62 : 20 - 21
  • [25] Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers
    Cristian C. Constantinescu
    Cedric Tresse
    MingQiang Zheng
    Alexandra Gouasmat
    Vincent M Carroll
    Laetitia Mistico
    David Alagille
    Christine M. Sandiego
    Caroline Papin
    Kenneth Marek
    John P. Seibyl
    Gilles D. Tamagnan
    Olivier Barret
    Molecular Imaging and Biology, 2019, 21 : 509 - 518
  • [26] The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study
    Onwordi, Ellis Chika
    Whitehurst, Thomas
    Shatalina, Ekaterina
    Carr, Richard
    Mansur, Ayla
    Arumuham, Atheeshaan
    Osugo, Martin
    Marques, Tiago Reis
    Jauhar, Sameer
    Gupta, Susham
    Pappa, Sofia
    Mehrotra, Ravi
    Ranger, Maja
    Rahaman, Nikola
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Natesan, Sridhar
    Howes, Oliver D.
    TRANSLATIONAL PSYCHIATRY, 2025, 15 (01):
  • [27] Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers
    Constantinescu, Cristian C.
    Tresse, Cedric
    Zheng, MingQiang
    Gouasmat, Alexandra
    Carroll, Vincent M.
    Mistico, Laetitia
    Alagille, David
    Sandiego, Christine M.
    Papin, Caroline
    Marek, Kenneth
    Seibyl, John P.
    Tamagnan, Gilles D.
    Barret, Olivier
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (03) : 509 - 518
  • [28] Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
    Nowack, Amy
    Malarkey, Erik B.
    Yao, Jia
    Bleckert, Adam
    Hill, Jessica
    Bajjalieh, Sandra M.
    PLOS ONE, 2011, 6 (12):
  • [29] PET imaging of pre-synaptic protein SV2A in Rett syndrome mouse model
    DiFilippo, Alexandra
    Ferreira, Carolina
    Engle, Jonathan
    Barnhart, Todd
    Dong, Qiping
    Chang, Qiang
    Christian, Bradley
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [30] Synaptic vesicle protein-2A(SV2A)regulates vesicular pool at sympathetic neuron synapses
    Tanifuji, Shota
    Vogl, Christian
    Stephens, Gary J.
    Mochida, Sumiko
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S188 - S188
12345